Turakhia Minang 4

What Happened

• Turakhia Minang, Chief Medical/Sci Officer and EVP Advanced Technology at iRhythm Holdings (IRTC), had 15,060 performance RSUs vest on Feb 24, 2026 (acquired at $0.00 per share) and sold 7,804 shares on Feb 25, 2026 in an open-market/related sale at $135.42 per share, generating proceeds of $1,056,809. The sale was reported on a Form 4 filed Feb 26, 2026.

Key Details

• Transaction dates and prices:
  • 2026-02-24: Award/acquisition of 15,060 shares (performance RSUs vested) @ $0.00 (Footnote F1).
  • 2026-02-25: Sale of 7,804 shares @ $135.42 = $1,056,809 (Footnote F2).
• Purpose of sale: Footnote F2 states the shares were sold to cover tax withholding and remittance obligations related to the RSU vesting.
• Shares owned after the transactions: Not specified in the Form 4 filing.
• Filing: Form 4 filed 2026-02-26 (covers 2/24–2/25 transactions); no indication in the filing that it was late.
• Corporate note: On Jan 12, 2026 iRhythm Tech completed a holding company reorganization; all prior shares/equity converted one-for-one to iRhythm Holdings securities (see Remarks).

Context

• This filing documents RSU vesting and a related sale to cover taxes — a common, routine action following equity award vesting. The filing is informational; it does not state any change in ongoing ownership beyond the amounts reported.